Vycor Medical Inc (VYCO) financial statements (2021 and earlier)

Company profile

Business Address 951 BROKEN SOUND PARKWAY
BOCA RATON,, FL 33487
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments46757171729963
Cash and cash equivalents46757171729963
Receivables15913797163278215295
Inventory, net of allowances, customer advances and progress billings181180194201211227253
Inventory181180194201211227253
Disposal group, including discontinued operation127    
Other undisclosed current assets7791761079611677
Total current assets:464485445542656656688
Noncurrent Assets
Operating lease, right-of-use asset124135146156324454
Property, plant and equipment381389391409375354351
Intangible assets, net (including goodwill)11      
Intangible assets, net (excluding goodwill)11      
Disposal group, including discontinued operation, noncurrent assets  7    
Other noncurrent assets     66
Other undisclosed noncurrent assets6202326292629
Total noncurrent assets:523544567591436430441
TOTAL ASSETS:9871,0291,0111,1331,0921,0861,129
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities637247278421561466465
Accounts payable179131171251252198155
Accrued liabilities117116107170309268310
Employee-related liabilities12      
Interest and dividends payable329      
Debt385556388347356395372
Due to related parties1,6083111,1351,135973973811
Disposal group, including discontinued operation41067    
Other undisclosed current liabilities1071,725717677557519502
Total current liabilities:2,7412,8492,5842,5802,4462,3532,150
Noncurrent Liabilities
Long-term debt and lease obligation22788100111  8
Long-term debt, excluding current maturities150      
Finance lease, liability 88100111   
Operating lease, liability77     8
Total noncurrent liabilities:22788100111  8
Total liabilities:2,9682,9372,6852,6912,4462,3532,158
Stockholders' equity
Stockholders' equity attributable to parent(1,981)(1,907)(1,673)(1,558)(1,354)(1,267)(1,029)
Preferred stock0000000
Common stock3333322
Treasury stock, value(1)(1)(1)(1)(1)(1)(1)
Additional paid in capital28,82628,70028,57328,44028,30728,17328,040
Accumulated other comprehensive income128128128128128128128
Accumulated deficit(30,937)(30,737)(30,376)(30,127)(29,790)(29,569)(29,197)
Total stockholders' equity:(1,981)(1,907)(1,673)(1,558)(1,354)(1,267)(1,029)
TOTAL LIABILITIES AND EQUITY:9871,0291,0111,1331,0921,0861,129

Income statement (P&L) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues292276244351355346430
Cost of revenue
(Cost of Goods and Services Sold)
(34)(41)(20)(39)(40)(32)(39)
Gross profit:257235224312315315391
Operating expenses(432)(442)(423)(469)(518)(506)(558)
Operating loss:(175)(206)(199)(156)(203)(192)(167)
Nonoperating expense(20)(14)(20)(19)(18)(18)(18)
Interest and debt expense(12)(12)(12)(12)(12)(12)(12)
Other undisclosed income from continuing operations before equity method investments, income taxes1,671      
Income (loss) from continuing operations before equity method investments, income taxes:1,464(233)(231)(187)(233)(222)(197)
Other undisclosed income (loss) from continuing operations before income taxes(2,869)454450362454431383
Income (loss) from continuing operations before income taxes:(1,405)221219175221210185
Other undisclosed income (loss) from continuing operations1,210(442)(438)    
Income (loss) from continuing operations:(195)(221)(219)175221210185
Income (loss) from discontinued operations(5)23(30)    
Net income (loss):(200)(198)(249)175221210185
Other undisclosed net loss attributable to parent   (350)(442)(419)(371)
Net loss attributable to parent:(200)(198)(249)(175)(221)(210)(185)
Preferred stock dividends and other adjustments (162) (162) (162) 
Net loss available to common stockholders, diluted:(200)(360)(249)(337)(221)(372)(185)

Comprehensive Income ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):(200)(198)(249)175221210185
Other comprehensive income (loss)(0)0 0(0)(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(200)(198)(249)175221210185

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: